search this site
- home
- our strategy
- highlights
- chief executive's review
- unaudited consolidated income statement
- unaudited consolidated balance sheets
- unaudited consolidated statements of changes in equity
- unaudited consolidated cash flow statements
- notes to the unaudited consolidated financial statements
- statement of directors' responsibilities
- independent review report to sinclair pharma plc
- corporate advisors
Sinclair Pharma plc is an international specialty pharma company.
We have a growing sales and marketing operation that is already
present in
France, Italy, the UK, Spain and Portugal, and a
complementary network of marketing partners in 82 countries.
Sinclair acquires, registers and commercialises undervalued products.
We currently focus on the niche therapeutic areas of oral health and dermatology.
We extract full value from each of our brands by a combination of sales through our own sales operations and marketing partners.
Our current portfolio includes 26 registered products in the EU and 10 in the US.
